Overall, these findings deepen our understanding of the molecular changes linked to high‐risk HPV infections and identify PI3K, MALAT1 and H19 as promising biomarkers and therapeutic targets for cervical cancer. The gene discussed is H19; the disease is cervical carcinoma.